These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 9167526

  • 1. Vitamin C for paroxetine- and fluvoxamine-associated bleeding.
    Tielens JA.
    Am J Psychiatry; 1997 Jun; 154(6):883-4. PubMed ID: 9167526
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fluvoxamine-associated bleeding.
    Leung M, Shore R.
    Can J Psychiatry; 1996 Nov; 41(9):604-5. PubMed ID: 8946088
    [No Abstract] [Full Text] [Related]

  • 4. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H, Yoshimura R, Ueda N, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J.
    World J Biol Psychiatry; 2009 Nov; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bleeding, a side effect of fluoxetine.
    Aranth J, Lindberg C.
    Am J Psychiatry; 1992 Mar; 149(3):412. PubMed ID: 1536285
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A, Feiger A.
    J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
    [Abstract] [Full Text] [Related]

  • 11. Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.
    Ueda N, Terao T, Ohmori O, Nakamura J.
    Hum Psychopharmacol; 2003 Aug; 18(6):477-8. PubMed ID: 12923827
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The abrupt discontinuation of fluvoxamine in patients with panic disorder.
    Black DW, Wesner R, Gabel J.
    J Clin Psychiatry; 1993 Apr; 54(4):146-9. PubMed ID: 8486592
    [Abstract] [Full Text] [Related]

  • 14. SSRIs associated with behavioral activation and suicidal ideation.
    Vorstman J, Lahuis B, Buitelaar JK.
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1364-5. PubMed ID: 11765279
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors.
    Fux M, Taub M, Zohar J.
    Acta Psychiatr Scand; 1993 Oct; 88(4):235-7. PubMed ID: 8256637
    [Abstract] [Full Text] [Related]

  • 19. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
    Nardi AE, Valença AM, Freire RC, Mochcovitch MD, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O E Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, Mezzasalma MA, de Carvalho MR, de Cerqueira AC, Hallak JE, Crippa JA, Versiani M.
    Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.